Fabio Gelsomino

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio et al. · The Lancet Oncology · 2022 · 270 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio et al. · Journal of Clinical Oncology · 2024 · 50 citations

Medicine, Pharmacology, Gastrointestinal Oncology +1

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study

Giulia Mentrasti, Luca Cantini, Clizia Zichi et al. · The Oncologist · 2022 · 32 citations · Full text

Medicine, Oncology, Cancer Screening +16

A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study final results.

Stefano Tamberi, Grassi Elisa, Chiara Zingaretti et al. · Journal of Clinical Oncology · 2022 · 32 citations

Medicine, Oncology, Pharmacotherapy +16

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group

Emanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani et al. · Cancers · 2021 · 21 citations · Full text

Medicine, Oncology, Pharmacology +15